Test Category
Part II: Planning the unplannable: 5 key considerations for pharma marketeers in 2021
This is the second part of a two-part series. Read the first part here. Here we continue to explore the…
Test Category
Part I: Planning the unplannable: 5 key considerations for pharma marketeers in 2021
This is the first part of a two-part series. Read the second part here. In this article you’ll learn: The…
Test Category
Pharma marketing in a post COVID-19 world
In this article you'll learn: The changes in HCP / patient behaviour in light of COVID-19 The key considerations for…
Test Category
How to reach HCPs on social media: are you missing out?
In this article you’ll learn: Why social media is a ripe environment for reaching HCPs How to find which channels…
Test Category
Enabling a medical device company to unlock the potential of social media
Introduction Our client had recently launched European-focussed consumer and HCP facing websites designed to raise awareness of heart valve disease,…
Test Category
Leveraging social media to drive HCP app installs
Introduction Our client had successfully developed an app designed to educate European GPs on early diagnosis of heart valve disease.…
Test Category
Using Facebook for data capture: distributing patient information packs
Introduction Our client had invested substantial resources in producing a physical patient information pack about a serious heart condition affecting…
Test Category
Implementing a pan-European unified eCRM platform
Introduction Our client was keen to leverage the benefits of marketing automation in communicating with an HCP audience, but its…
Test Category
Developing a best in class HCP resource for HIV
Introduction Our client challenged us to develop a comprehensive digital communication strategy designed to effectively reach specialist and generalist HCPs…
Test Category
How pharma can harness the influence of Digital Opinion Leaders
In this article you'll learn: How Digital Opinion Leaders differ from Key Opinion Leaders How to identify Digital Opinion Leaders…
12